目錄:杭州斯達(dá)特生物科技有限公司>>抗體/抗原>>Biosimilar抗體>> S0B0561Anti-PD-L1 Monoclonal Antibody(Durvalumab)
Durvalumab is an immunotherapy for cancer. It is a human immunoglobulin G1 kappa (IgG1κ) monoclonal antibody that blocks the interaction of programmed cell death ligand 1 (PD-L1) with the PD-1 (CD279).
(空格分隔,最多3個,單個標(biāo)簽最多10個字符)